Cargando…
Cardiometabolic medicine: a review of the current proposed approaches to revamped training in the United States
Cardiovascular disease (CVD) remains the leading cause of mortality in the United States, and the population of patients with cardiometabolic conditions, including obesity, metabolic syndrome and diabetes mellitus, continues to grow. There is a need for physicians with specific training in cardiomet...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352603/ https://www.ncbi.nlm.nih.gov/pubmed/34386718 http://dx.doi.org/10.1097/XCE.0000000000000243 |
_version_ | 1783736217525813248 |
---|---|
author | Soroosh, Garshasb P. Dzaye, Omar Reiter-Brennan, Cara Blaha, Michael J. |
author_facet | Soroosh, Garshasb P. Dzaye, Omar Reiter-Brennan, Cara Blaha, Michael J. |
author_sort | Soroosh, Garshasb P. |
collection | PubMed |
description | Cardiovascular disease (CVD) remains the leading cause of mortality in the United States, and the population of patients with cardiometabolic conditions, including obesity, metabolic syndrome and diabetes mellitus, continues to grow. There is a need for physicians with specific training in cardiometabolic medicine to provide a ‘medical home’ for patients with cardiometabolic disease, rather than the fractured care that currently exists in the United States. Cardiometabolic specialists will head multidisciplinary clinics, develop practice guidelines, and lead through research. Proposals for US training in cardiometabolic medicine include: maintain the current training model, a dedicated 2–3 year fellowship following internal medicine residency, a 1-year fellowship following either internal medicine residency or fellowship in cardiology or endocrinology, and certification available to any interested clinician. This review discusses the pros and cons of these approaches. The authors believe that a dedicated cardiometabolic training fellowship has significant advantages over the other options. |
format | Online Article Text |
id | pubmed-8352603 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-83526032021-08-11 Cardiometabolic medicine: a review of the current proposed approaches to revamped training in the United States Soroosh, Garshasb P. Dzaye, Omar Reiter-Brennan, Cara Blaha, Michael J. Cardiovasc Endocrinol Metab Review Cardiovascular disease (CVD) remains the leading cause of mortality in the United States, and the population of patients with cardiometabolic conditions, including obesity, metabolic syndrome and diabetes mellitus, continues to grow. There is a need for physicians with specific training in cardiometabolic medicine to provide a ‘medical home’ for patients with cardiometabolic disease, rather than the fractured care that currently exists in the United States. Cardiometabolic specialists will head multidisciplinary clinics, develop practice guidelines, and lead through research. Proposals for US training in cardiometabolic medicine include: maintain the current training model, a dedicated 2–3 year fellowship following internal medicine residency, a 1-year fellowship following either internal medicine residency or fellowship in cardiology or endocrinology, and certification available to any interested clinician. This review discusses the pros and cons of these approaches. The authors believe that a dedicated cardiometabolic training fellowship has significant advantages over the other options. Wolters Kluwer Health 2021-01-27 /pmc/articles/PMC8352603/ /pubmed/34386718 http://dx.doi.org/10.1097/XCE.0000000000000243 Text en Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Review Soroosh, Garshasb P. Dzaye, Omar Reiter-Brennan, Cara Blaha, Michael J. Cardiometabolic medicine: a review of the current proposed approaches to revamped training in the United States |
title | Cardiometabolic medicine: a review of the current proposed approaches to revamped training in the United States |
title_full | Cardiometabolic medicine: a review of the current proposed approaches to revamped training in the United States |
title_fullStr | Cardiometabolic medicine: a review of the current proposed approaches to revamped training in the United States |
title_full_unstemmed | Cardiometabolic medicine: a review of the current proposed approaches to revamped training in the United States |
title_short | Cardiometabolic medicine: a review of the current proposed approaches to revamped training in the United States |
title_sort | cardiometabolic medicine: a review of the current proposed approaches to revamped training in the united states |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352603/ https://www.ncbi.nlm.nih.gov/pubmed/34386718 http://dx.doi.org/10.1097/XCE.0000000000000243 |
work_keys_str_mv | AT sorooshgarshasbp cardiometabolicmedicineareviewofthecurrentproposedapproachestorevampedtrainingintheunitedstates AT dzayeomar cardiometabolicmedicineareviewofthecurrentproposedapproachestorevampedtrainingintheunitedstates AT reiterbrennancara cardiometabolicmedicineareviewofthecurrentproposedapproachestorevampedtrainingintheunitedstates AT blahamichaelj cardiometabolicmedicineareviewofthecurrentproposedapproachestorevampedtrainingintheunitedstates |